Revenue Performance - Revenue for the three months ended September 30, 2025, was $1,446,917, a 1% increase from $1,435,376 in the same period of 2024[131] - Revenue for the nine months ended September 30, 2025, was $4,562,604, a 12% decrease from $5,211,665 in the same period of 2024[132] Profit and Loss - Gross profit for the three months ended September 30, 2025, was $493,307, a 6% increase from $464,445 in the same period of 2024[131] - Net loss for the three months ended September 30, 2025, was $(2,731,341), a 239% increase from $(804,987) in the same period of 2024[131] Expenses - Selling, general and administrative expenses for the three months ended September 30, 2025, were $2,372,465, a 90% increase from $1,245,428 in the same period of 2024[134] - The Company reported a significant increase in consulting and professional fees, rising by $304,136 for the three months ended September 30, 2025, due to preparations for its initial public offering[134] Cash Flow - Cash used in operating activities for the nine months ended September 30, 2025, was $(3,887,737), a decrease of $(5,151,263) compared to cash provided by operating activities of $1,263,526 in the same period of 2024[140] - Cash provided by financing activities for the nine months ended September 30, 2025, was $5,196,432, an increase of $8,760,108 compared to $(3,563,676) in the same period of 2024[142] Financing Activities - The Company entered into an ELOC Facility allowing the sale of up to $25 million of common stock, with 123,208 shares issued for net proceeds of approximately $497,750 as of September 30, 2025[136][138] Seasonal Trends - The Company expects seasonal revenue fluctuations, typically highest in the third and fourth quarters and lowest in the first and second quarters[130]

Financial Performance - Revenues for Q3 2025 were $1.4 million, a slight increase from $1.4 million in Q3 2024, while revenues for the nine months ended September 30, 2025, were $4.6 million, down from $5.2 million in the same period last year [12]. - Gross profit for Q3 2025 was $0.5 million, compared to $0.5 million in Q3 2024, and for the nine months ended September 30, 2025, gross profit was $1.8 million, down from $2.1 million in the prior year [12]. - Loss from operations for Q3 2025 was ($1.9) million, compared to a loss of ($0.8) million in Q3 2024, and for the nine months ended September 30, 2025, the loss was ($4.5) million, up from ($1.0) million in the prior year [12]. - Net income for the nine months ended September 30, 2025, was a loss of $5,373,327, compared to a loss of $998,596 for the same period in 2024 [14]. - Net cash provided by (used in) operating activities was $(3,887,737) for the nine months ended September 30, 2025, compared to $1,263,526 in 2024 [14]. - Cash flows used in investing activities totaled $(616,896) for the nine months ended September 30, 2025, compared to $(46,167) in 2024 [14]. - Net cash provided by financing activities was $5,196,432 for the nine months ended September 30, 2025, compared to $(3,563,676) in 2024 [14]. - The company reported stock-based compensation of $1,154,842 for the nine months ended September 30, 2025 [14]. - The company experienced a decrease in accounts receivable of $(395,995) compared to an increase of $1,803,724 in 2024 [14]. - The company reported a decrease in inventory of $(64,883) for the nine months ended September 30, 2025, compared to an increase of $7,086 in 2024 [14]. - Proceeds from IPO and overallotment, net, amounted to $4,543,988 for the nine months ended September 30, 2025 [14]. - The company had a cash flow increase of $691,799 in cash and cash equivalents for the nine months ended September 30, 2025, compared to a decrease of $(2,346,317) in 2024 [14]. Operational Developments - The Company extended its emergency preparedness contract with the City of Chicago through June 2026, increasing total contract value to $9.1 million with an additional $1.5 million in funding [6]. - The Company established a subsidiary in India, Callan JMB Services (India) Private Limited, with plans for a temperature-controlled warehouse for pharmaceutical storage and distribution [6]. - The Company upgraded its Sentry Monitoring System to version 4.0, enhancing temperature monitoring capabilities for healthcare facilities and emergency management agencies [6]. - The Company entered a preliminary agreement to install oral drug delivery equipment at its cGMP facility in Texas, supporting future logistics operations for international pharmaceutical companies [6]. Cash and Assets - Cash and cash equivalents as of September 30, 2025, were $2.8 million, an increase from $2.1 million at the end of 2024 [10]. - Total assets as of September 30, 2025, were $7.7 million, compared to $5.1 million at the end of 2024 [10]. - Cash and cash equivalents at the end of the period were $2,789,744, a decrease from $2,809,303 at the end of the same period in 2024 [14].

Core Insights - Callan JMB Inc. is expanding its logistics platform into the food sampling industry and has entered agreements to enhance its pharmaceutical logistics capabilities [1][2][3] - The company has established a subsidiary in India to support temperature-controlled pharmaceutical storage and distribution [2][3] - A long-term contract with the City of Chicago has been extended through June 2026, with an increase in funding [2][3] Business Developments - The company has launched operations in the food sampling sector as part of its strategic growth initiatives [2][3] - A preliminary agreement has been made to install oral drug delivery system manufacturing equipment in Texas [2][3] - Callan JMB Services (India) Private Limited has been formed, with plans for a temperature-controlled warehouse in Pune, Maharashtra [2][3] Financial Performance - Revenues for Q3 2025 were $1.4 million, a slight increase from $1.4 million in Q3 2024, while revenues for the nine months ended September 30, 2025, were $4.6 million, down from $5.2 million in the same period last year [8][10] - Gross profit for Q3 2025 was $0.5 million, compared to $0.46 million in Q3 2024, and for the nine months ended September 30, 2025, it was $1.8 million, down from $2.1 million [8][11] - The company reported a net loss of $2.7 million for Q3 2025, compared to a loss of $0.8 million in Q3 2024, and a net loss of $5.4 million for the nine months ended September 30, 2025, compared to a loss of $1.0 million in the same period last year [10][11] Technology Enhancements - The Sentry Monitoring System has been upgraded to version 4.0, allowing for improved temperature monitoring capabilities across devices [2][3]

Agreement is the latest step in execution of the Company’s strategy to support onshoring of logistical and operational activities for international companies to the U.S. SPRING BRANCH, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has entered a preli ...

Core Insights - Callan JMB Inc. is expanding its reclamation operations into the food sampling industry, leveraging its expertise in regulated materials to tap into sustainable, high-growth consumer markets [1][4] - The company aims to apply its compliance-driven logistics model to meet the specialized needs of food brands and distributors, enhancing product integrity and traceability [2][4] Industry Context - The food logistics market is valued at over $120 billion globally, with an annual growth rate of 6-10%, providing a strong platform for Callan JMB's expansion into food sampling services [5] - The U.S. specialty food sector is projected to reach $130 billion by 2032, indicating significant growth potential in this area [6] Strategic Partnerships - Callan JMB's expansion is supported by its relationship with Keychain, an AI-powered platform that connects manufacturers with brands and retailers, facilitating faster and more responsible product launches [4][8] - Keychain supports over $1 billion in monthly manufacturing projects, highlighting the scale and impact of this partnership [4] Sustainability Focus - The initiative addresses the growing demand for sustainable packaging and waste-reduction practices in food sampling, filling an accountability gap in the industry [3][5] - Callan JMB's compliance infrastructure is designed to help brands meet sustainability expectations while ensuring product quality [5]

Core Viewpoint - Callan JMB Inc. is expanding its reclamation operations into the food sampling industry through a partnership with Keychain, aiming to enhance compliance and sustainability in this high-growth market [1][2][3]. Company Strategy - The partnership with Keychain, an AI-enabled platform, is part of Callan JMB's growth strategy to penetrate neighboring markets that are experiencing significant growth [2]. - The company is already collaborating with established players in the food sampling sector to improve compliance and sustainability in their distribution models [3]. Management Commentary - CEO Wayne Williams emphasized the importance of compliance infrastructure in ensuring safety and accountability, drawing parallels between the food sampling and pharmaceutical industries [3]. - The initiative aims to reduce waste and protect product quality while meeting consumer expectations, reflecting a broader strategy to apply sustainable logistics across various industries [3]. Recent Earnings - In August 2025, Callan JMB reported a second-quarter loss of $0.31 per share, compared to a loss of $0.04 in the previous year, with revenue of $1.666 million, down from $1.986 million year-over-year [4]. - Despite the earnings report, CJMB shares closed higher by 4.45% at $3.99 [4].

Core Insights - Callan JMB INC. has upgraded its Sentry Monitoring System to version 4.0, enhancing flexibility and accessibility for remote monitoring of temperature-sensitive pharmaceutical products [1][2][4] Product Features - The Sentry Monitoring System allows for 24/7/365 active monitoring, alarm notifications, and compliant reporting data, now with improved accessibility through HTML5, enabling users to manage alarms from any device with a web browser [2][3] - Users can access a consistent interface across various devices, including PCs, Macs, iPhones, Androids, and tablets, allowing for real-time monitoring and management of environmental anomalies in pharmaceutical storage [3] Company Overview - Callan JMB is an integrative logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [5] - The company emphasizes its expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, aiming to provide a high standard of client experience [5]

Core Insights - Callan JMB INC. is participating in the LD Micro Main Event XIX Conference scheduled for October 19-21, 2025, where they will present on October 21 at 12:00 PM PT [1][2] Company Overview - Callan JMB is an integrative logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [3] - The company aims to secure medical materials and protect patients and communities by providing compliant, safe, and effective medicines [3] - Callan JMB boasts unparalleled expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness [3] - The company emphasizes a high standard of client experience with customizable interfaces, reliable shipping, and environmentally sustainable specialty packaging [3]

As filed with the U.S. Securities and Exchange Commission on September 19, 2025 Registration No. 333- 289849 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Primary Standard Industrial Classification Code Number) Nevada 7389 99-0931141 (I.R.S. Employer Identification Number) 244 Flightline Drive Spring Branch, Texas 78070-6241 (830) 438-0395 CALLAN JMB INC. (Exact name of registrant as specified in i ...

Core Insights - Callan JMB INC. is an integrative logistics company focused on empowering the healthcare industry and emergency management agencies through various logistics services [1][3] - The company will participate in two investment conferences in September 2025, providing opportunities for investor engagement [2] Company Overview - Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services aimed at securing medical materials and ensuring patient safety [3] - The company boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness [3] - Callan JMB emphasizes a high standard of client experience with customizable interfaces and reliable shipping, alongside a commitment to environmental sustainability in packaging [3] Upcoming Events - The H.C. Wainwright 27 Annual Global Investment Conference will take place from September 8-10, 2025, with a presentation available on demand starting September 5, 2025 [2] - The iAccess Alpha Virtual Best Ideas Fall Investment Conference is scheduled for September 16-17, 2025, with a presentation on September 16, 2025, at 10:30 a.m. ET [2] - Management will conduct one-on-one investor meetings during both conferences, with scheduling available through designated representatives [2]